GSK PLC (GLAXF)
21.14
+0.14
(+0.67%)
USD |
OTCM |
May 03, 16:00
GSK 1 Year Total Returns (Daily): 23.81% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 23.81% |
| May 02, 2024 | 22.99% |
| May 01, 2024 | 22.06% |
| April 30, 2024 | 21.96% |
| April 29, 2024 | 24.89% |
| April 26, 2024 | 16.01% |
| April 25, 2024 | 8.51% |
| April 24, 2024 | 13.15% |
| April 23, 2024 | 10.70% |
| April 22, 2024 | 15.04% |
| April 19, 2024 | 13.58% |
| April 18, 2024 | 13.79% |
| April 17, 2024 | 7.53% |
| April 16, 2024 | 12.66% |
| April 15, 2024 | 12.66% |
| April 12, 2024 | 12.54% |
| April 11, 2024 | 14.06% |
| April 10, 2024 | 14.24% |
| April 09, 2024 | 11.77% |
| April 08, 2024 | 11.28% |
| April 05, 2024 | 14.87% |
| April 04, 2024 | 21.38% |
| April 03, 2024 | 25.08% |
| April 02, 2024 | 20.87% |
| April 01, 2024 | 16.22% |
| Date | Value |
|---|---|
| March 28, 2024 | 26.90% |
| March 27, 2024 | 29.64% |
| March 26, 2024 | 27.76% |
| March 25, 2024 | 32.58% |
| March 22, 2024 | 21.67% |
| March 21, 2024 | 26.26% |
| March 20, 2024 | 27.27% |
| March 19, 2024 | 28.71% |
| March 18, 2024 | 29.48% |
| March 15, 2024 | 33.82% |
| March 14, 2024 | 32.22% |
| March 13, 2024 | 33.30% |
| March 12, 2024 | 27.01% |
| March 11, 2024 | 27.01% |
| March 08, 2024 | 31.29% |
| March 07, 2024 | 28.50% |
| March 06, 2024 | 25.27% |
| March 05, 2024 | 26.13% |
| March 04, 2024 | 26.13% |
| March 01, 2024 | 27.97% |
| February 29, 2024 | 25.12% |
| February 28, 2024 | 25.63% |
| February 27, 2024 | 27.30% |
| February 26, 2024 | 27.02% |
| February 23, 2024 | 28.54% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-39.58%
Minimum
Sep 22 2022
39.41%
Maximum
Sep 22 2023
1.11%
Average
5.50%
Median
Nov 17 2023
1 Year Total Returns (Daily) Benchmarks
| Adaptimmune Therapeutics PLC | -15.00% |
| Biodexa Pharmaceuticals Plc | -93.25% |
| Verona Pharma PLC | -25.96% |
| NuCana PLC | -78.47% |
| Autolus Therapeutics PLC | 113.8% |